Listen to an archived version of our recent webinar where PathoQuest and other experts in the field to gain insights on the latest NGS biosafety testing and characterization strategies for biologics and the impact of the recent revisions to ICH Q5A.

The speakers will provide insights on the revisions to ICH Q5A and the incorporation of next-generation sequencing (NGS) as an accepted testing methodology, review the results of a recent study comparing the use of NGS to In Vivo testing for QC testing of biologics, and describe the value of using NGS for identity testing of biologics.

To register and view the webinar, go to: https://us02web.zoom.us/webinar/register/WN_PNXw3EHMR5KZm37t0jQjMA

Use passcode: bfJm8v$Q

For more information contact sales_marketing@pathoquest.com